Taros, a privately owned chemistry CRO and custom synthesis provider has been serving pharmaceutical, biotech and chemical companies since 1999.
Within our drug discovery division, we provide holistic medicinal chemistry services to clients on their way to the next clinical candidate. Having a strong scientific track record on many biomolecular targets in all main therapeutic areas we add considerable value to collaborations from target validation and hit identification to lead optimization.
Our chemical services include discovery chemistry, custom synthesis, process chemistry, medicinal chemistry, computational chemistry and molecular modeling, as well as the design of compound libraries and the production of screening compounds.
Taros was leading the chemistry activities of the European Lead Factory (ELF), a EUR 196 m drug discovery platform and is also the lead of its recent continuation (ESCulab) funded with EUR 36.5 m.